HuGE Literature Finder
Records 1-6
|
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma.
Acta neuropathologica communications 2019 Apr 7 (1): 66. Tanaka Shota, Batchelor Tracy T, Iafrate A John, Dias-Santagata Dora, Borger Darrell R, Ellisen Leif W, Yang Daniel, Louis David N, Cahill Daniel P, Chi Andrew |
|
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
|
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.
Acta neuropathologica communications 2018 10 6 (1): 106. Williams Erik A, Miller Julie J, Tummala Shilpa S, Penson Tristan, Iafrate A John, Juratli Tareq A, Cahill Daniel |
|
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.
Oncotarget 2016 Feb . Schwaederle Maria, Husain Hatim, Fanta Paul T, Piccioni David E, Kesari Santosh, Schwab Richard B, Banks Kimberly C, Lanman Richard B, Talasaz AmirAli, Parker Barbara A, Kurzrock Razel |
|
Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation.
Oncology letters 2015 May 9 (5): 2063-2067. McDonald Kerrie L, Tabone Tania, Nowak Anna K, Erber Wendy |
|
Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.
International journal of clinical and experimental pathology 2015 8 (5): 5327-35. Tang Chao, Guo Jun, Chen Hong, Yao Cheng-Jun, Zhuang Dong-Xiao, Wang Yin, Tang Wei-Jun, Ren Guang, Yao Yu, Wu Jin-Song, Mao Ying, Zhou Liang- |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: